103 related articles for article (PubMed ID: 3390371)
21. [In vitro drug-resistance decrease of ovarian cancer cells].
Lu SM
Zhonghua Fu Chan Ke Za Zhi; 1990 Nov; 25(6):348-51, 383. PubMed ID: 2282862
[TBL] [Abstract][Full Text] [Related]
22. Variation in the duration of mitosis in the crypts of Lieberkuhn of the rat; a cytokinetic study using vincristine.
Wright N; Morley A; Appleton D
Cell Tissue Kinet; 1972 Jul; 5(4):351-64. PubMed ID: 5044626
[No Abstract] [Full Text] [Related]
23. Reversal of chemoresistance in malignant gliomas by calcium antagonists: correlation with the expression of multidrug-resistant p-glycoprotein.
Kiwit JC; Hertel A; Matuschek AE
J Neurosurg; 1994 Oct; 81(4):587-94. PubMed ID: 7931593
[TBL] [Abstract][Full Text] [Related]
24. Development of PLGA nanoparticles simultaneously loaded with vincristine and verapamil for treatment of hepatocellular carcinoma.
Song XR; Zheng Y; He G; Yang L; Luo YF; He ZY; Li SZ; Li JM; Yu S; Luo X; Hou SX; Wei YQ
J Pharm Sci; 2010 Dec; 99(12):4874-9. PubMed ID: 20821385
[TBL] [Abstract][Full Text] [Related]
25. Properties of verapamil-hypersensitive multidrug-resistant Chinese hamster ovary cells.
Warr JR; Anderson M; Fergusson J
Cancer Res; 1988 Aug; 48(16):4477-83. PubMed ID: 2899455
[TBL] [Abstract][Full Text] [Related]
26. Verapamil reversal of vincristine resistance and cross-resistance patterns of vincristine-resistant Chinese hamster ovary cells.
Brewer F; Warr JR
Cancer Treat Rep; 1987 Apr; 71(4):353-9. PubMed ID: 2881620
[TBL] [Abstract][Full Text] [Related]
27. Addition of verapamil to overcome drug resistance in multiple myeloma: preliminary clinical observations in 10 patients.
Trümper LH; Ho AD; Wulf G; Hunstein W
J Clin Oncol; 1989 Oct; 7(10):1578-9. PubMed ID: 2778486
[No Abstract] [Full Text] [Related]
28. Human colorectal tumours in short-term organ culture. A stathmokinetic study.
Pritchett CJ; Senior PV; Sunter JP; Watson AJ; Appleton DR; Wilson RG
Cell Tissue Kinet; 1982 Sep; 15(5):555-64. PubMed ID: 7127403
[TBL] [Abstract][Full Text] [Related]
29. Circumvention of multidrug resistance by a newly synthesized quinoline derivative, MS-073.
Sato W; Fukazawa N; Suzuki T; Yusa K; Tsuruo T
Cancer Res; 1991 May; 51(9):2420-4. PubMed ID: 1673087
[TBL] [Abstract][Full Text] [Related]
30. Promotion by verapamil of vincristine responsiveness in tumor cell lines inherently resistant to the drug.
Tsuruo T; Iida H; Naganuma K; Tsukagoshi S; Sakurai Y
Cancer Res; 1983 Feb; 43(2):808-13. PubMed ID: 6848194
[TBL] [Abstract][Full Text] [Related]
31. Circumvention of pleiotropic drug resistance in subcutaneous tumours in vivo with verapamil and clomipramine.
Merry S; Hamilton TG; Flanigan P; Freshney RI; Kaye SB
Eur J Cancer; 1991; 27(1):31-4. PubMed ID: 1826436
[TBL] [Abstract][Full Text] [Related]
32. R-dl-verapamil downmodulates multidrug resistance of KBv200 cells to vincristine and doxorubicin.
Fang G; Yang YL; Li JS; Zhang ZX
Zhongguo Yao Li Xue Bao; 1999 Jul; 20(7):647-50. PubMed ID: 10678132
[TBL] [Abstract][Full Text] [Related]
33. Effects of androgen manipulations on chemically induced colonic tumours and on macroscopically normal colonic mucosa in male Sprague-Dawley rats.
Izbicki JR; Hamilton SR; Wambach G; Harnisch E; Wilker DK; Dornschneider G; Eibl-Eibesfeldt B; Schweiberer L
Br J Cancer; 1990 Feb; 61(2):235-40. PubMed ID: 2138029
[TBL] [Abstract][Full Text] [Related]
34. The effect of cyclophosphamide and vincristine on intestinal protein loss in rats.
Beró T; Jávor T
Arch Toxicol Suppl; 1985; 8():117-21. PubMed ID: 3868340
[TBL] [Abstract][Full Text] [Related]
35. Verapamil sensitisation to alkaloids on colchicine-selected human colon adenocarcinoma cells.
Ruiz Gómez MJ; Souviron A; Gil L; Martínez Morillo M
J Physiol Biochem; 2001 Dec; 57(4):343-4. PubMed ID: 12005037
[No Abstract] [Full Text] [Related]
36. [The effect of verapamil on the growth and sensitivity to vincristine of human tumor transplanted into kidney capsule of mice].
Storozhenko IV; Sergeeva NS; Chissov VI; Skotnikova OI
Biull Eksp Biol Med; 1996 Jun; 121(6):681-3. PubMed ID: 9035766
[No Abstract] [Full Text] [Related]
37. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A
Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233
[TBL] [Abstract][Full Text] [Related]
38. Verapamil enhances antitumor activity without increasing myeloid toxicity.
Morrow M; Wait RB; Rosenthal RA; Gamelli RL
Surgery; 1987 Jan; 101(1):63-8. PubMed ID: 3798329
[TBL] [Abstract][Full Text] [Related]
39. An LC-MS/MS method for simultaneous determination of vincristine and verapamil in rat plasma after oral administration of a dual agent formulation.
Ling G; Zhang P; Sun J; Zhang W; Fu Q; Zhang T; Deng Y; He Z
Biomed Chromatogr; 2011 Sep; 25(9):963-9. PubMed ID: 21823137
[TBL] [Abstract][Full Text] [Related]
40. Effects of verapamil on etoposide, vincristine, and adriamycin activity in normal human bone marrow granulocyte-macrophage progenitors and in human K562 leukemia cells in vitro.
Yalowich JC; Zucali JR; Gross M; Ross WE
Cancer Res; 1985 Oct; 45(10):4921-4. PubMed ID: 3861238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
